Global CRISPR Gene Editing Therapy Supply, Demand and Key Producers, 2026-2032
The global CRISPR Gene Editing Therapy market size is expected to reach $ 655 million by 2032, rising at a market growth of 5.0% CAGR during the forecast period (2026-2032).
CRISPR Gene Editing Therapy is a treatment method that utilizes the CRISPR-Cas9 system for precise gene editing. The CRISPR-Cas9 system, derived from bacteria and archaea, is an immune system that recognizes and cuts specific DNA sequences. In gene editing therapy, scientists leverage this property of the CRISPR-Cas9 system by designing specific RNA molecules to guide the Cas9 enzyme to cut the DNA sequence of the target gene, enabling the addition, deletion, or replacement of genes. This therapy holds great potential in treating genetic diseases, cancer, infectious diseases, and more. By directly correcting the disease-causing genes, CRISPR Gene Editing Therapy has the potential to provide radical treatments for patients, improving or even curing these diseases.
CRISPR gene editing therapy sits within a value chain that begins upstream with the development of core biological components?Cas enzymes (Cas9, Cas12, Cas13), guide RNA synthesis, delivery systems (viral vectors, lipid nanoparticles, RNP complexes), and specialized laboratory tools such as sequencing platforms, reagents, and cell-culture systems. These inputs feed into technology providers and research institutions that design, optimize, and validate CRISPR constructs, therapeutic pipelines, and agricultural or industrial applications. Downstream, CRISPR-enabled products and services flow into biotechnology and pharmaceutical companies developing gene therapies, diagnostics, and engineered cell lines; agricultural firms creating improved crops; and industrial or academic labs using CRISPR for basic research. Regulatory agencies, clinical trial service providers, and intellectual-property licensors form the final part of the chain. In short, CRISPR gene editing relies on an upstream supply of enzymes, guide RNAs, and delivery technologies, and serves downstream markets in therapeutics, diagnostics, agriculture, and scientific research.
CRISPR gene editing is moving from a high-growth research technology toward a diversified commercial market driven first by therapeutic pipelines and secondarily by diagnostics and agriculture. Clinical progress?an increasing number of CRISPR, base-editing and prime-editing trials (ex vivo and in vivo) is driving near-term value creation as companies advance toward pivotal data and potential approvals. Strategic partnerships, licensing deals and selective M&A (including large pharma buying early-stage gene-editing assets) are re-shaping capital flows and derisking programs for big-pharma commercialization. However, the market?s pace and addressable value depend heavily on solving delivery, safety and regulatory hurdles?efficient, tissue-specific delivery (LNPs, AAVs and next-gen vectors), off-target risk reduction, and clear regulatory pathways remain critical technical and adoption barriers. Finally, non-therapeutic applications (crop improvement, livestock traits, industrial biotech, and rapid CRISPR-based diagnostics) represent sizable adjacent markets that both diversify revenue streams and raise regionally divergent regulatory and public-acceptance questions that investors and developers must manage.
This report studies the global CRISPR Gene Editing Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CRISPR Gene Editing Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of CRISPR Gene Editing Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CRISPR Gene Editing Therapy total market, 2021-2032, (USD Million)
Global CRISPR Gene Editing Therapy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: CRISPR Gene Editing Therapy total market, key domestic companies, and share, (USD Million)
Global CRISPR Gene Editing Therapy revenue by player, revenue and market share 2021-2026, (USD Million)
Global CRISPR Gene Editing Therapy total market by Tool Type, CAGR, 2021-2032, (USD Million)
Global CRISPR Gene Editing Therapy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global CRISPR Gene Editing Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Merck KGaA, Integrated DNA Technologies (IDT), Takara Bio, New England Biolabs, GenScript, Aldevron, TriLink Biotechnologies, Synthego, KACTUS Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world CRISPR Gene Editing Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Tool Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global CRISPR Gene Editing Therapy Market, By Region:
1. How big is the global CRISPR Gene Editing Therapy market?
2. What is the demand of the global CRISPR Gene Editing Therapy market?
3. What is the year over year growth of the global CRISPR Gene Editing Therapy market?
4. What is the total value of the global CRISPR Gene Editing Therapy market?
5. Who are the Major Players in the global CRISPR Gene Editing Therapy market?
6. What are the growth factors driving the market demand?
CRISPR Gene Editing Therapy is a treatment method that utilizes the CRISPR-Cas9 system for precise gene editing. The CRISPR-Cas9 system, derived from bacteria and archaea, is an immune system that recognizes and cuts specific DNA sequences. In gene editing therapy, scientists leverage this property of the CRISPR-Cas9 system by designing specific RNA molecules to guide the Cas9 enzyme to cut the DNA sequence of the target gene, enabling the addition, deletion, or replacement of genes. This therapy holds great potential in treating genetic diseases, cancer, infectious diseases, and more. By directly correcting the disease-causing genes, CRISPR Gene Editing Therapy has the potential to provide radical treatments for patients, improving or even curing these diseases.
CRISPR gene editing therapy sits within a value chain that begins upstream with the development of core biological components?Cas enzymes (Cas9, Cas12, Cas13), guide RNA synthesis, delivery systems (viral vectors, lipid nanoparticles, RNP complexes), and specialized laboratory tools such as sequencing platforms, reagents, and cell-culture systems. These inputs feed into technology providers and research institutions that design, optimize, and validate CRISPR constructs, therapeutic pipelines, and agricultural or industrial applications. Downstream, CRISPR-enabled products and services flow into biotechnology and pharmaceutical companies developing gene therapies, diagnostics, and engineered cell lines; agricultural firms creating improved crops; and industrial or academic labs using CRISPR for basic research. Regulatory agencies, clinical trial service providers, and intellectual-property licensors form the final part of the chain. In short, CRISPR gene editing relies on an upstream supply of enzymes, guide RNAs, and delivery technologies, and serves downstream markets in therapeutics, diagnostics, agriculture, and scientific research.
CRISPR gene editing is moving from a high-growth research technology toward a diversified commercial market driven first by therapeutic pipelines and secondarily by diagnostics and agriculture. Clinical progress?an increasing number of CRISPR, base-editing and prime-editing trials (ex vivo and in vivo) is driving near-term value creation as companies advance toward pivotal data and potential approvals. Strategic partnerships, licensing deals and selective M&A (including large pharma buying early-stage gene-editing assets) are re-shaping capital flows and derisking programs for big-pharma commercialization. However, the market?s pace and addressable value depend heavily on solving delivery, safety and regulatory hurdles?efficient, tissue-specific delivery (LNPs, AAVs and next-gen vectors), off-target risk reduction, and clear regulatory pathways remain critical technical and adoption barriers. Finally, non-therapeutic applications (crop improvement, livestock traits, industrial biotech, and rapid CRISPR-based diagnostics) represent sizable adjacent markets that both diversify revenue streams and raise regionally divergent regulatory and public-acceptance questions that investors and developers must manage.
This report studies the global CRISPR Gene Editing Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CRISPR Gene Editing Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of CRISPR Gene Editing Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CRISPR Gene Editing Therapy total market, 2021-2032, (USD Million)
Global CRISPR Gene Editing Therapy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: CRISPR Gene Editing Therapy total market, key domestic companies, and share, (USD Million)
Global CRISPR Gene Editing Therapy revenue by player, revenue and market share 2021-2026, (USD Million)
Global CRISPR Gene Editing Therapy total market by Tool Type, CAGR, 2021-2032, (USD Million)
Global CRISPR Gene Editing Therapy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global CRISPR Gene Editing Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Merck KGaA, Integrated DNA Technologies (IDT), Takara Bio, New England Biolabs, GenScript, Aldevron, TriLink Biotechnologies, Synthego, KACTUS Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world CRISPR Gene Editing Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Tool Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global CRISPR Gene Editing Therapy Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- DNA-Cutting Tools
- DNA-Editing Without Double-Strand Breaks
- RNA Editing Tools
- Others
- Research Grade
- GMP Grade
- CRISPR-Cas9
- CRISPR-Cas12a (Cpf1)
- Base Editors (CBE & ABE)
- Others
- Agricultural
- Biomedical
- Industrial
- Others
- Thermo Fisher Scientific
- Merck KGaA
- Integrated DNA Technologies (IDT)
- Takara Bio
- New England Biolabs
- GenScript
- Aldevron
- TriLink Biotechnologies
- Synthego
- KACTUS Bio
- Fortis Life Sciences
- Shandong Shunfeng Biotechnology
- Renman Biotechnology
1. How big is the global CRISPR Gene Editing Therapy market?
2. What is the demand of the global CRISPR Gene Editing Therapy market?
3. What is the year over year growth of the global CRISPR Gene Editing Therapy market?
4. What is the total value of the global CRISPR Gene Editing Therapy market?
5. Who are the Major Players in the global CRISPR Gene Editing Therapy market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 CRISPR Gene Editing Therapy Introduction
1.2 World CRISPR Gene Editing Therapy Market Size & Forecast (2021 & 2025 & 2032)
1.3 World CRISPR Gene Editing Therapy Total Market by Region (by Headquarter Location)
1.3.1 World CRISPR Gene Editing Therapy Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company CRISPR Gene Editing Therapy Revenue (2021-2032)
1.3.3 China Based Company CRISPR Gene Editing Therapy Revenue (2021-2032)
1.3.4 Europe Based Company CRISPR Gene Editing Therapy Revenue (2021-2032)
1.3.5 Japan Based Company CRISPR Gene Editing Therapy Revenue (2021-2032)
1.3.6 South Korea Based Company CRISPR Gene Editing Therapy Revenue (2021-2032)
1.3.7 ASEAN Based Company CRISPR Gene Editing Therapy Revenue (2021-2032)
1.3.8 India Based Company CRISPR Gene Editing Therapy Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 CRISPR Gene Editing Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World CRISPR Gene Editing Therapy Consumption Value (2021-2032)
2.2 World CRISPR Gene Editing Therapy Consumption Value by Region
2.2.1 World CRISPR Gene Editing Therapy Consumption Value by Region (2021-2026)
2.2.2 World CRISPR Gene Editing Therapy Consumption Value Forecast by Region (2027-2032)
2.3 United States CRISPR Gene Editing Therapy Consumption Value (2021-2032)
2.4 China CRISPR Gene Editing Therapy Consumption Value (2021-2032)
2.5 Europe CRISPR Gene Editing Therapy Consumption Value (2021-2032)
2.6 Japan CRISPR Gene Editing Therapy Consumption Value (2021-2032)
2.7 South Korea CRISPR Gene Editing Therapy Consumption Value (2021-2032)
2.8 ASEAN CRISPR Gene Editing Therapy Consumption Value (2021-2032)
2.9 India CRISPR Gene Editing Therapy Consumption Value (2021-2032)
3 WORLD CRISPR GENE EDITING THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World CRISPR Gene Editing Therapy Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CRISPR Gene Editing Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CRISPR Gene Editing Therapy in 2025
3.2.3 Global Concentration Ratios (CR8) for CRISPR Gene Editing Therapy in 2025
3.3 CRISPR Gene Editing Therapy Company Evaluation Quadrant
3.4 CRISPR Gene Editing Therapy Market: Overall Company Footprint Analysis
3.4.1 CRISPR Gene Editing Therapy Market: Region Footprint
3.4.2 CRISPR Gene Editing Therapy Market: Company Product Type Footprint
3.4.3 CRISPR Gene Editing Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: CRISPR Gene Editing Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CRISPR Gene Editing Therapy Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: CRISPR Gene Editing Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: CRISPR Gene Editing Therapy Consumption Value Comparison
4.2.1 United States VS China: CRISPR Gene Editing Therapy Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: CRISPR Gene Editing Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based CRISPR Gene Editing Therapy Companies and Market Share, 2021-2026
4.3.1 United States Based CRISPR Gene Editing Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CRISPR Gene Editing Therapy Revenue, (2021-2026)
4.4 China Based Companies CRISPR Gene Editing Therapy Revenue and Market Share, 2021-2026
4.4.1 China Based CRISPR Gene Editing Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CRISPR Gene Editing Therapy Revenue, (2021-2026)
4.5 Rest of World Based CRISPR Gene Editing Therapy Companies and Market Share, 2021-2026
4.5.1 Rest of World Based CRISPR Gene Editing Therapy Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies CRISPR Gene Editing Therapy Revenue (2021-2026)
5 MARKET ANALYSIS BY TOOL TYPE
5.1 World CRISPR Gene Editing Therapy Market Size Overview by Tool Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Tool Type
5.2.1 DNA-Cutting Tools
5.2.2 DNA-Editing Without Double-Strand Breaks
5.2.3 RNA Editing Tools
5.2.4 Others
5.3 Market Segment by Tool Type
5.3.1 World CRISPR Gene Editing Therapy Market Size by Tool Type (2021-2026)
5.3.2 World CRISPR Gene Editing Therapy Market Size by Tool Type (2027-2032)
5.3.3 World CRISPR Gene Editing Therapy Market Size Market Share by Tool Type (2027-2032)
6 MARKET ANALYSIS BY GRADE
6.1 World CRISPR Gene Editing Therapy Market Size Overview by Grade: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Grade
6.2.1 Research Grade
6.2.2 GMP Grade
6.3 Market Segment by Grade
6.3.1 World CRISPR Gene Editing Therapy Market Size by Grade (2021-2026)
6.3.2 World CRISPR Gene Editing Therapy Market Size by Grade (2027-2032)
6.3.3 World CRISPR Gene Editing Therapy Market Size Market Share by Grade (2027-2032)
7 MARKET ANALYSIS BY PRODUCT TYPE
7.1 World CRISPR Gene Editing Therapy Market Size Overview by Product Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Type
7.2.1 CRISPR-Cas9
7.2.2 CRISPR-Cas12a (Cpf1)
7.2.3 Base Editors (CBE & ABE)
7.2.4 Others
7.3 Market Segment by Product Type
7.3.1 World CRISPR Gene Editing Therapy Market Size by Product Type (2021-2026)
7.3.2 World CRISPR Gene Editing Therapy Market Size by Product Type (2027-2032)
7.3.3 World CRISPR Gene Editing Therapy Market Size Market Share by Product Type (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World CRISPR Gene Editing Therapy Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Agricultural
8.2.2 Biomedical
8.2.3 Industrial
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World CRISPR Gene Editing Therapy Market Size by Application (2021-2026)
8.3.2 World CRISPR Gene Editing Therapy Market Size by Application (2027-2032)
8.3.3 World CRISPR Gene Editing Therapy Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Details
9.1.2 Thermo Fisher Scientific Major Business
9.1.3 Thermo Fisher Scientific CRISPR Gene Editing Therapy Product and Services
9.1.4 Thermo Fisher Scientific CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Thermo Fisher Scientific Recent Developments/Updates
9.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.2 Merck KGaA
9.2.1 Merck KGaA Details
9.2.2 Merck KGaA Major Business
9.2.3 Merck KGaA CRISPR Gene Editing Therapy Product and Services
9.2.4 Merck KGaA CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Merck KGaA Recent Developments/Updates
9.2.6 Merck KGaA Competitive Strengths & Weaknesses
9.3 Integrated DNA Technologies (IDT)
9.3.1 Integrated DNA Technologies (IDT) Details
9.3.2 Integrated DNA Technologies (IDT) Major Business
9.3.3 Integrated DNA Technologies (IDT) CRISPR Gene Editing Therapy Product and Services
9.3.4 Integrated DNA Technologies (IDT) CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Integrated DNA Technologies (IDT) Recent Developments/Updates
9.3.6 Integrated DNA Technologies (IDT) Competitive Strengths & Weaknesses
9.4 Takara Bio
9.4.1 Takara Bio Details
9.4.2 Takara Bio Major Business
9.4.3 Takara Bio CRISPR Gene Editing Therapy Product and Services
9.4.4 Takara Bio CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Takara Bio Recent Developments/Updates
9.4.6 Takara Bio Competitive Strengths & Weaknesses
9.5 New England Biolabs
9.5.1 New England Biolabs Details
9.5.2 New England Biolabs Major Business
9.5.3 New England Biolabs CRISPR Gene Editing Therapy Product and Services
9.5.4 New England Biolabs CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 New England Biolabs Recent Developments/Updates
9.5.6 New England Biolabs Competitive Strengths & Weaknesses
9.6 GenScript
9.6.1 GenScript Details
9.6.2 GenScript Major Business
9.6.3 GenScript CRISPR Gene Editing Therapy Product and Services
9.6.4 GenScript CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 GenScript Recent Developments/Updates
9.6.6 GenScript Competitive Strengths & Weaknesses
9.7 Aldevron
9.7.1 Aldevron Details
9.7.2 Aldevron Major Business
9.7.3 Aldevron CRISPR Gene Editing Therapy Product and Services
9.7.4 Aldevron CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Aldevron Recent Developments/Updates
9.7.6 Aldevron Competitive Strengths & Weaknesses
9.8 TriLink Biotechnologies
9.8.1 TriLink Biotechnologies Details
9.8.2 TriLink Biotechnologies Major Business
9.8.3 TriLink Biotechnologies CRISPR Gene Editing Therapy Product and Services
9.8.4 TriLink Biotechnologies CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 TriLink Biotechnologies Recent Developments/Updates
9.8.6 TriLink Biotechnologies Competitive Strengths & Weaknesses
9.9 Synthego
9.9.1 Synthego Details
9.9.2 Synthego Major Business
9.9.3 Synthego CRISPR Gene Editing Therapy Product and Services
9.9.4 Synthego CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Synthego Recent Developments/Updates
9.9.6 Synthego Competitive Strengths & Weaknesses
9.10 KACTUS Bio
9.10.1 KACTUS Bio Details
9.10.2 KACTUS Bio Major Business
9.10.3 KACTUS Bio CRISPR Gene Editing Therapy Product and Services
9.10.4 KACTUS Bio CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 KACTUS Bio Recent Developments/Updates
9.10.6 KACTUS Bio Competitive Strengths & Weaknesses
9.11 Fortis Life Sciences
9.11.1 Fortis Life Sciences Details
9.11.2 Fortis Life Sciences Major Business
9.11.3 Fortis Life Sciences CRISPR Gene Editing Therapy Product and Services
9.11.4 Fortis Life Sciences CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Fortis Life Sciences Recent Developments/Updates
9.11.6 Fortis Life Sciences Competitive Strengths & Weaknesses
9.12 Shandong Shunfeng Biotechnology
9.12.1 Shandong Shunfeng Biotechnology Details
9.12.2 Shandong Shunfeng Biotechnology Major Business
9.12.3 Shandong Shunfeng Biotechnology CRISPR Gene Editing Therapy Product and Services
9.12.4 Shandong Shunfeng Biotechnology CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Shandong Shunfeng Biotechnology Recent Developments/Updates
9.12.6 Shandong Shunfeng Biotechnology Competitive Strengths & Weaknesses
9.13 Renman Biotechnology
9.13.1 Renman Biotechnology Details
9.13.2 Renman Biotechnology Major Business
9.13.3 Renman Biotechnology CRISPR Gene Editing Therapy Product and Services
9.13.4 Renman Biotechnology CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Renman Biotechnology Recent Developments/Updates
9.13.6 Renman Biotechnology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 CRISPR Gene Editing Therapy Industry Chain
10.2 CRISPR Gene Editing Therapy Upstream Analysis
10.3 CRISPR Gene Editing Therapy Midstream Analysis
10.4 CRISPR Gene Editing Therapy Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 CRISPR Gene Editing Therapy Introduction
1.2 World CRISPR Gene Editing Therapy Market Size & Forecast (2021 & 2025 & 2032)
1.3 World CRISPR Gene Editing Therapy Total Market by Region (by Headquarter Location)
1.3.1 World CRISPR Gene Editing Therapy Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company CRISPR Gene Editing Therapy Revenue (2021-2032)
1.3.3 China Based Company CRISPR Gene Editing Therapy Revenue (2021-2032)
1.3.4 Europe Based Company CRISPR Gene Editing Therapy Revenue (2021-2032)
1.3.5 Japan Based Company CRISPR Gene Editing Therapy Revenue (2021-2032)
1.3.6 South Korea Based Company CRISPR Gene Editing Therapy Revenue (2021-2032)
1.3.7 ASEAN Based Company CRISPR Gene Editing Therapy Revenue (2021-2032)
1.3.8 India Based Company CRISPR Gene Editing Therapy Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 CRISPR Gene Editing Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World CRISPR Gene Editing Therapy Consumption Value (2021-2032)
2.2 World CRISPR Gene Editing Therapy Consumption Value by Region
2.2.1 World CRISPR Gene Editing Therapy Consumption Value by Region (2021-2026)
2.2.2 World CRISPR Gene Editing Therapy Consumption Value Forecast by Region (2027-2032)
2.3 United States CRISPR Gene Editing Therapy Consumption Value (2021-2032)
2.4 China CRISPR Gene Editing Therapy Consumption Value (2021-2032)
2.5 Europe CRISPR Gene Editing Therapy Consumption Value (2021-2032)
2.6 Japan CRISPR Gene Editing Therapy Consumption Value (2021-2032)
2.7 South Korea CRISPR Gene Editing Therapy Consumption Value (2021-2032)
2.8 ASEAN CRISPR Gene Editing Therapy Consumption Value (2021-2032)
2.9 India CRISPR Gene Editing Therapy Consumption Value (2021-2032)
3 WORLD CRISPR GENE EDITING THERAPY COMPANIES COMPETITIVE ANALYSIS
3.1 World CRISPR Gene Editing Therapy Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CRISPR Gene Editing Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CRISPR Gene Editing Therapy in 2025
3.2.3 Global Concentration Ratios (CR8) for CRISPR Gene Editing Therapy in 2025
3.3 CRISPR Gene Editing Therapy Company Evaluation Quadrant
3.4 CRISPR Gene Editing Therapy Market: Overall Company Footprint Analysis
3.4.1 CRISPR Gene Editing Therapy Market: Region Footprint
3.4.2 CRISPR Gene Editing Therapy Market: Company Product Type Footprint
3.4.3 CRISPR Gene Editing Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: CRISPR Gene Editing Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CRISPR Gene Editing Therapy Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: CRISPR Gene Editing Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: CRISPR Gene Editing Therapy Consumption Value Comparison
4.2.1 United States VS China: CRISPR Gene Editing Therapy Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: CRISPR Gene Editing Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based CRISPR Gene Editing Therapy Companies and Market Share, 2021-2026
4.3.1 United States Based CRISPR Gene Editing Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CRISPR Gene Editing Therapy Revenue, (2021-2026)
4.4 China Based Companies CRISPR Gene Editing Therapy Revenue and Market Share, 2021-2026
4.4.1 China Based CRISPR Gene Editing Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CRISPR Gene Editing Therapy Revenue, (2021-2026)
4.5 Rest of World Based CRISPR Gene Editing Therapy Companies and Market Share, 2021-2026
4.5.1 Rest of World Based CRISPR Gene Editing Therapy Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies CRISPR Gene Editing Therapy Revenue (2021-2026)
5 MARKET ANALYSIS BY TOOL TYPE
5.1 World CRISPR Gene Editing Therapy Market Size Overview by Tool Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Tool Type
5.2.1 DNA-Cutting Tools
5.2.2 DNA-Editing Without Double-Strand Breaks
5.2.3 RNA Editing Tools
5.2.4 Others
5.3 Market Segment by Tool Type
5.3.1 World CRISPR Gene Editing Therapy Market Size by Tool Type (2021-2026)
5.3.2 World CRISPR Gene Editing Therapy Market Size by Tool Type (2027-2032)
5.3.3 World CRISPR Gene Editing Therapy Market Size Market Share by Tool Type (2027-2032)
6 MARKET ANALYSIS BY GRADE
6.1 World CRISPR Gene Editing Therapy Market Size Overview by Grade: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Grade
6.2.1 Research Grade
6.2.2 GMP Grade
6.3 Market Segment by Grade
6.3.1 World CRISPR Gene Editing Therapy Market Size by Grade (2021-2026)
6.3.2 World CRISPR Gene Editing Therapy Market Size by Grade (2027-2032)
6.3.3 World CRISPR Gene Editing Therapy Market Size Market Share by Grade (2027-2032)
7 MARKET ANALYSIS BY PRODUCT TYPE
7.1 World CRISPR Gene Editing Therapy Market Size Overview by Product Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Type
7.2.1 CRISPR-Cas9
7.2.2 CRISPR-Cas12a (Cpf1)
7.2.3 Base Editors (CBE & ABE)
7.2.4 Others
7.3 Market Segment by Product Type
7.3.1 World CRISPR Gene Editing Therapy Market Size by Product Type (2021-2026)
7.3.2 World CRISPR Gene Editing Therapy Market Size by Product Type (2027-2032)
7.3.3 World CRISPR Gene Editing Therapy Market Size Market Share by Product Type (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World CRISPR Gene Editing Therapy Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Agricultural
8.2.2 Biomedical
8.2.3 Industrial
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World CRISPR Gene Editing Therapy Market Size by Application (2021-2026)
8.3.2 World CRISPR Gene Editing Therapy Market Size by Application (2027-2032)
8.3.3 World CRISPR Gene Editing Therapy Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Details
9.1.2 Thermo Fisher Scientific Major Business
9.1.3 Thermo Fisher Scientific CRISPR Gene Editing Therapy Product and Services
9.1.4 Thermo Fisher Scientific CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Thermo Fisher Scientific Recent Developments/Updates
9.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.2 Merck KGaA
9.2.1 Merck KGaA Details
9.2.2 Merck KGaA Major Business
9.2.3 Merck KGaA CRISPR Gene Editing Therapy Product and Services
9.2.4 Merck KGaA CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Merck KGaA Recent Developments/Updates
9.2.6 Merck KGaA Competitive Strengths & Weaknesses
9.3 Integrated DNA Technologies (IDT)
9.3.1 Integrated DNA Technologies (IDT) Details
9.3.2 Integrated DNA Technologies (IDT) Major Business
9.3.3 Integrated DNA Technologies (IDT) CRISPR Gene Editing Therapy Product and Services
9.3.4 Integrated DNA Technologies (IDT) CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Integrated DNA Technologies (IDT) Recent Developments/Updates
9.3.6 Integrated DNA Technologies (IDT) Competitive Strengths & Weaknesses
9.4 Takara Bio
9.4.1 Takara Bio Details
9.4.2 Takara Bio Major Business
9.4.3 Takara Bio CRISPR Gene Editing Therapy Product and Services
9.4.4 Takara Bio CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Takara Bio Recent Developments/Updates
9.4.6 Takara Bio Competitive Strengths & Weaknesses
9.5 New England Biolabs
9.5.1 New England Biolabs Details
9.5.2 New England Biolabs Major Business
9.5.3 New England Biolabs CRISPR Gene Editing Therapy Product and Services
9.5.4 New England Biolabs CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 New England Biolabs Recent Developments/Updates
9.5.6 New England Biolabs Competitive Strengths & Weaknesses
9.6 GenScript
9.6.1 GenScript Details
9.6.2 GenScript Major Business
9.6.3 GenScript CRISPR Gene Editing Therapy Product and Services
9.6.4 GenScript CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 GenScript Recent Developments/Updates
9.6.6 GenScript Competitive Strengths & Weaknesses
9.7 Aldevron
9.7.1 Aldevron Details
9.7.2 Aldevron Major Business
9.7.3 Aldevron CRISPR Gene Editing Therapy Product and Services
9.7.4 Aldevron CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Aldevron Recent Developments/Updates
9.7.6 Aldevron Competitive Strengths & Weaknesses
9.8 TriLink Biotechnologies
9.8.1 TriLink Biotechnologies Details
9.8.2 TriLink Biotechnologies Major Business
9.8.3 TriLink Biotechnologies CRISPR Gene Editing Therapy Product and Services
9.8.4 TriLink Biotechnologies CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 TriLink Biotechnologies Recent Developments/Updates
9.8.6 TriLink Biotechnologies Competitive Strengths & Weaknesses
9.9 Synthego
9.9.1 Synthego Details
9.9.2 Synthego Major Business
9.9.3 Synthego CRISPR Gene Editing Therapy Product and Services
9.9.4 Synthego CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Synthego Recent Developments/Updates
9.9.6 Synthego Competitive Strengths & Weaknesses
9.10 KACTUS Bio
9.10.1 KACTUS Bio Details
9.10.2 KACTUS Bio Major Business
9.10.3 KACTUS Bio CRISPR Gene Editing Therapy Product and Services
9.10.4 KACTUS Bio CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 KACTUS Bio Recent Developments/Updates
9.10.6 KACTUS Bio Competitive Strengths & Weaknesses
9.11 Fortis Life Sciences
9.11.1 Fortis Life Sciences Details
9.11.2 Fortis Life Sciences Major Business
9.11.3 Fortis Life Sciences CRISPR Gene Editing Therapy Product and Services
9.11.4 Fortis Life Sciences CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Fortis Life Sciences Recent Developments/Updates
9.11.6 Fortis Life Sciences Competitive Strengths & Weaknesses
9.12 Shandong Shunfeng Biotechnology
9.12.1 Shandong Shunfeng Biotechnology Details
9.12.2 Shandong Shunfeng Biotechnology Major Business
9.12.3 Shandong Shunfeng Biotechnology CRISPR Gene Editing Therapy Product and Services
9.12.4 Shandong Shunfeng Biotechnology CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Shandong Shunfeng Biotechnology Recent Developments/Updates
9.12.6 Shandong Shunfeng Biotechnology Competitive Strengths & Weaknesses
9.13 Renman Biotechnology
9.13.1 Renman Biotechnology Details
9.13.2 Renman Biotechnology Major Business
9.13.3 Renman Biotechnology CRISPR Gene Editing Therapy Product and Services
9.13.4 Renman Biotechnology CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Renman Biotechnology Recent Developments/Updates
9.13.6 Renman Biotechnology Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 CRISPR Gene Editing Therapy Industry Chain
10.2 CRISPR Gene Editing Therapy Upstream Analysis
10.3 CRISPR Gene Editing Therapy Midstream Analysis
10.4 CRISPR Gene Editing Therapy Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World CRISPR Gene Editing Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World CRISPR Gene Editing Therapy Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World CRISPR Gene Editing Therapy Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World CRISPR Gene Editing Therapy Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World CRISPR Gene Editing Therapy Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World CRISPR Gene Editing Therapy Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World CRISPR Gene Editing Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World CRISPR Gene Editing Therapy Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World CRISPR Gene Editing Therapy Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key CRISPR Gene Editing Therapy Players in 2025
Table 12. World CRISPR Gene Editing Therapy Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global CRISPR Gene Editing Therapy Company Evaluation Quadrant
Table 14. Head Office of Key CRISPR Gene Editing Therapy Players
Table 15. CRISPR Gene Editing Therapy Market: Company Product Type Footprint
Table 16. CRISPR Gene Editing Therapy Market: Company Product Application Footprint
Table 17. CRISPR Gene Editing Therapy Mergers & Acquisitions Activity
Table 18. United States VS China CRISPR Gene Editing Therapy Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China CRISPR Gene Editing Therapy Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based CRISPR Gene Editing Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies CRISPR Gene Editing Therapy Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies CRISPR Gene Editing Therapy Revenue Market Share (2021-2026)
Table 23. China Based CRISPR Gene Editing Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies CRISPR Gene Editing Therapy Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies CRISPR Gene Editing Therapy Revenue Market Share (2021-2026)
Table 26. Rest of World Based CRISPR Gene Editing Therapy Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies CRISPR Gene Editing Therapy Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies CRISPR Gene Editing Therapy Revenue Market Share (2021-2026)
Table 29. World CRISPR Gene Editing Therapy Market Size by Tool Type, (USD Million), 2021 & 2025 & 2032
Table 30. World CRISPR Gene Editing Therapy Market Size Value by Tool Type (2021-2026) & (USD Million)
Table 31. World CRISPR Gene Editing Therapy Market Size by Tool Type (2027-2032) & (USD Million)
Table 32. World CRISPR Gene Editing Therapy Market Size by Grade, (USD Million), 2021 & 2025 & 2032
Table 33. World CRISPR Gene Editing Therapy Market Size Value by Grade (2021-2026) & (USD Million)
Table 34. World CRISPR Gene Editing Therapy Market Size by Grade (2027-2032) & (USD Million)
Table 35. World CRISPR Gene Editing Therapy Market Size by Product Type, (USD Million), 2021 & 2025 & 2032
Table 36. World CRISPR Gene Editing Therapy Market Size Value by Product Type (2021-2026) & (USD Million)
Table 37. World CRISPR Gene Editing Therapy Market Size by Product Type (2027-2032) & (USD Million)
Table 38. World CRISPR Gene Editing Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World CRISPR Gene Editing Therapy Market Size by Application (2021-2026) & (USD Million)
Table 40. World CRISPR Gene Editing Therapy Market Size by Application (2027-2032) & (USD Million)
Table 41. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific CRISPR Gene Editing Therapy Product and Services
Table 44. Thermo Fisher Scientific CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 48. Merck KGaA Major Business
Table 49. Merck KGaA CRISPR Gene Editing Therapy Product and Services
Table 50. Merck KGaA CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Merck KGaA Recent Developments/Updates
Table 52. Merck KGaA Competitive Strengths & Weaknesses
Table 53. Integrated DNA Technologies (IDT) Basic Information, Manufacturing Base and Competitors
Table 54. Integrated DNA Technologies (IDT) Major Business
Table 55. Integrated DNA Technologies (IDT) CRISPR Gene Editing Therapy Product and Services
Table 56. Integrated DNA Technologies (IDT) CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Integrated DNA Technologies (IDT) Recent Developments/Updates
Table 58. Integrated DNA Technologies (IDT) Competitive Strengths & Weaknesses
Table 59. Takara Bio Basic Information, Manufacturing Base and Competitors
Table 60. Takara Bio Major Business
Table 61. Takara Bio CRISPR Gene Editing Therapy Product and Services
Table 62. Takara Bio CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Takara Bio Recent Developments/Updates
Table 64. Takara Bio Competitive Strengths & Weaknesses
Table 65. New England Biolabs Basic Information, Manufacturing Base and Competitors
Table 66. New England Biolabs Major Business
Table 67. New England Biolabs CRISPR Gene Editing Therapy Product and Services
Table 68. New England Biolabs CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. New England Biolabs Recent Developments/Updates
Table 70. New England Biolabs Competitive Strengths & Weaknesses
Table 71. GenScript Basic Information, Manufacturing Base and Competitors
Table 72. GenScript Major Business
Table 73. GenScript CRISPR Gene Editing Therapy Product and Services
Table 74. GenScript CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. GenScript Recent Developments/Updates
Table 76. GenScript Competitive Strengths & Weaknesses
Table 77. Aldevron Basic Information, Manufacturing Base and Competitors
Table 78. Aldevron Major Business
Table 79. Aldevron CRISPR Gene Editing Therapy Product and Services
Table 80. Aldevron CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Aldevron Recent Developments/Updates
Table 82. Aldevron Competitive Strengths & Weaknesses
Table 83. TriLink Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 84. TriLink Biotechnologies Major Business
Table 85. TriLink Biotechnologies CRISPR Gene Editing Therapy Product and Services
Table 86. TriLink Biotechnologies CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. TriLink Biotechnologies Recent Developments/Updates
Table 88. TriLink Biotechnologies Competitive Strengths & Weaknesses
Table 89. Synthego Basic Information, Manufacturing Base and Competitors
Table 90. Synthego Major Business
Table 91. Synthego CRISPR Gene Editing Therapy Product and Services
Table 92. Synthego CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Synthego Recent Developments/Updates
Table 94. Synthego Competitive Strengths & Weaknesses
Table 95. KACTUS Bio Basic Information, Manufacturing Base and Competitors
Table 96. KACTUS Bio Major Business
Table 97. KACTUS Bio CRISPR Gene Editing Therapy Product and Services
Table 98. KACTUS Bio CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. KACTUS Bio Recent Developments/Updates
Table 100. KACTUS Bio Competitive Strengths & Weaknesses
Table 101. Fortis Life Sciences Basic Information, Manufacturing Base and Competitors
Table 102. Fortis Life Sciences Major Business
Table 103. Fortis Life Sciences CRISPR Gene Editing Therapy Product and Services
Table 104. Fortis Life Sciences CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Fortis Life Sciences Recent Developments/Updates
Table 106. Fortis Life Sciences Competitive Strengths & Weaknesses
Table 107. Shandong Shunfeng Biotechnology Basic Information, Manufacturing Base and Competitors
Table 108. Shandong Shunfeng Biotechnology Major Business
Table 109. Shandong Shunfeng Biotechnology CRISPR Gene Editing Therapy Product and Services
Table 110. Shandong Shunfeng Biotechnology CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Shandong Shunfeng Biotechnology Recent Developments/Updates
Table 112. Shandong Shunfeng Biotechnology Competitive Strengths & Weaknesses
Table 113. Renman Biotechnology Basic Information, Manufacturing Base and Competitors
Table 114. Renman Biotechnology Major Business
Table 115. Renman Biotechnology CRISPR Gene Editing Therapy Product and Services
Table 116. Renman Biotechnology CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Renman Biotechnology Recent Developments/Updates
Table 118. Renman Biotechnology Competitive Strengths & Weaknesses
Table 119. Global Key Players of CRISPR Gene Editing Therapy Upstream (Raw Materials)
Table 120. Global CRISPR Gene Editing Therapy Typical Customers
Table 1. World CRISPR Gene Editing Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World CRISPR Gene Editing Therapy Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World CRISPR Gene Editing Therapy Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World CRISPR Gene Editing Therapy Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World CRISPR Gene Editing Therapy Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World CRISPR Gene Editing Therapy Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World CRISPR Gene Editing Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World CRISPR Gene Editing Therapy Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World CRISPR Gene Editing Therapy Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key CRISPR Gene Editing Therapy Players in 2025
Table 12. World CRISPR Gene Editing Therapy Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global CRISPR Gene Editing Therapy Company Evaluation Quadrant
Table 14. Head Office of Key CRISPR Gene Editing Therapy Players
Table 15. CRISPR Gene Editing Therapy Market: Company Product Type Footprint
Table 16. CRISPR Gene Editing Therapy Market: Company Product Application Footprint
Table 17. CRISPR Gene Editing Therapy Mergers & Acquisitions Activity
Table 18. United States VS China CRISPR Gene Editing Therapy Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China CRISPR Gene Editing Therapy Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based CRISPR Gene Editing Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies CRISPR Gene Editing Therapy Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies CRISPR Gene Editing Therapy Revenue Market Share (2021-2026)
Table 23. China Based CRISPR Gene Editing Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies CRISPR Gene Editing Therapy Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies CRISPR Gene Editing Therapy Revenue Market Share (2021-2026)
Table 26. Rest of World Based CRISPR Gene Editing Therapy Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies CRISPR Gene Editing Therapy Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies CRISPR Gene Editing Therapy Revenue Market Share (2021-2026)
Table 29. World CRISPR Gene Editing Therapy Market Size by Tool Type, (USD Million), 2021 & 2025 & 2032
Table 30. World CRISPR Gene Editing Therapy Market Size Value by Tool Type (2021-2026) & (USD Million)
Table 31. World CRISPR Gene Editing Therapy Market Size by Tool Type (2027-2032) & (USD Million)
Table 32. World CRISPR Gene Editing Therapy Market Size by Grade, (USD Million), 2021 & 2025 & 2032
Table 33. World CRISPR Gene Editing Therapy Market Size Value by Grade (2021-2026) & (USD Million)
Table 34. World CRISPR Gene Editing Therapy Market Size by Grade (2027-2032) & (USD Million)
Table 35. World CRISPR Gene Editing Therapy Market Size by Product Type, (USD Million), 2021 & 2025 & 2032
Table 36. World CRISPR Gene Editing Therapy Market Size Value by Product Type (2021-2026) & (USD Million)
Table 37. World CRISPR Gene Editing Therapy Market Size by Product Type (2027-2032) & (USD Million)
Table 38. World CRISPR Gene Editing Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World CRISPR Gene Editing Therapy Market Size by Application (2021-2026) & (USD Million)
Table 40. World CRISPR Gene Editing Therapy Market Size by Application (2027-2032) & (USD Million)
Table 41. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 42. Thermo Fisher Scientific Major Business
Table 43. Thermo Fisher Scientific CRISPR Gene Editing Therapy Product and Services
Table 44. Thermo Fisher Scientific CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Thermo Fisher Scientific Recent Developments/Updates
Table 46. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 47. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 48. Merck KGaA Major Business
Table 49. Merck KGaA CRISPR Gene Editing Therapy Product and Services
Table 50. Merck KGaA CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Merck KGaA Recent Developments/Updates
Table 52. Merck KGaA Competitive Strengths & Weaknesses
Table 53. Integrated DNA Technologies (IDT) Basic Information, Manufacturing Base and Competitors
Table 54. Integrated DNA Technologies (IDT) Major Business
Table 55. Integrated DNA Technologies (IDT) CRISPR Gene Editing Therapy Product and Services
Table 56. Integrated DNA Technologies (IDT) CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Integrated DNA Technologies (IDT) Recent Developments/Updates
Table 58. Integrated DNA Technologies (IDT) Competitive Strengths & Weaknesses
Table 59. Takara Bio Basic Information, Manufacturing Base and Competitors
Table 60. Takara Bio Major Business
Table 61. Takara Bio CRISPR Gene Editing Therapy Product and Services
Table 62. Takara Bio CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Takara Bio Recent Developments/Updates
Table 64. Takara Bio Competitive Strengths & Weaknesses
Table 65. New England Biolabs Basic Information, Manufacturing Base and Competitors
Table 66. New England Biolabs Major Business
Table 67. New England Biolabs CRISPR Gene Editing Therapy Product and Services
Table 68. New England Biolabs CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. New England Biolabs Recent Developments/Updates
Table 70. New England Biolabs Competitive Strengths & Weaknesses
Table 71. GenScript Basic Information, Manufacturing Base and Competitors
Table 72. GenScript Major Business
Table 73. GenScript CRISPR Gene Editing Therapy Product and Services
Table 74. GenScript CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. GenScript Recent Developments/Updates
Table 76. GenScript Competitive Strengths & Weaknesses
Table 77. Aldevron Basic Information, Manufacturing Base and Competitors
Table 78. Aldevron Major Business
Table 79. Aldevron CRISPR Gene Editing Therapy Product and Services
Table 80. Aldevron CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Aldevron Recent Developments/Updates
Table 82. Aldevron Competitive Strengths & Weaknesses
Table 83. TriLink Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 84. TriLink Biotechnologies Major Business
Table 85. TriLink Biotechnologies CRISPR Gene Editing Therapy Product and Services
Table 86. TriLink Biotechnologies CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. TriLink Biotechnologies Recent Developments/Updates
Table 88. TriLink Biotechnologies Competitive Strengths & Weaknesses
Table 89. Synthego Basic Information, Manufacturing Base and Competitors
Table 90. Synthego Major Business
Table 91. Synthego CRISPR Gene Editing Therapy Product and Services
Table 92. Synthego CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Synthego Recent Developments/Updates
Table 94. Synthego Competitive Strengths & Weaknesses
Table 95. KACTUS Bio Basic Information, Manufacturing Base and Competitors
Table 96. KACTUS Bio Major Business
Table 97. KACTUS Bio CRISPR Gene Editing Therapy Product and Services
Table 98. KACTUS Bio CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. KACTUS Bio Recent Developments/Updates
Table 100. KACTUS Bio Competitive Strengths & Weaknesses
Table 101. Fortis Life Sciences Basic Information, Manufacturing Base and Competitors
Table 102. Fortis Life Sciences Major Business
Table 103. Fortis Life Sciences CRISPR Gene Editing Therapy Product and Services
Table 104. Fortis Life Sciences CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Fortis Life Sciences Recent Developments/Updates
Table 106. Fortis Life Sciences Competitive Strengths & Weaknesses
Table 107. Shandong Shunfeng Biotechnology Basic Information, Manufacturing Base and Competitors
Table 108. Shandong Shunfeng Biotechnology Major Business
Table 109. Shandong Shunfeng Biotechnology CRISPR Gene Editing Therapy Product and Services
Table 110. Shandong Shunfeng Biotechnology CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Shandong Shunfeng Biotechnology Recent Developments/Updates
Table 112. Shandong Shunfeng Biotechnology Competitive Strengths & Weaknesses
Table 113. Renman Biotechnology Basic Information, Manufacturing Base and Competitors
Table 114. Renman Biotechnology Major Business
Table 115. Renman Biotechnology CRISPR Gene Editing Therapy Product and Services
Table 116. Renman Biotechnology CRISPR Gene Editing Therapy Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Renman Biotechnology Recent Developments/Updates
Table 118. Renman Biotechnology Competitive Strengths & Weaknesses
Table 119. Global Key Players of CRISPR Gene Editing Therapy Upstream (Raw Materials)
Table 120. Global CRISPR Gene Editing Therapy Typical Customers
LIST OF FIGURES
Figure 1. CRISPR Gene Editing Therapy Picture
Figure 2. World CRISPR Gene Editing Therapy Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World CRISPR Gene Editing Therapy Total Revenue (2021-2032) & (USD Million)
Figure 4. World CRISPR Gene Editing Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World CRISPR Gene Editing Therapy Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company CRISPR Gene Editing Therapy Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company CRISPR Gene Editing Therapy Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company CRISPR Gene Editing Therapy Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company CRISPR Gene Editing Therapy Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company CRISPR Gene Editing Therapy Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company CRISPR Gene Editing Therapy Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company CRISPR Gene Editing Therapy Revenue (2021-2032) & (USD Million)
Figure 13. CRISPR Gene Editing Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World CRISPR Gene Editing Therapy Consumption Value (2021-2032) & (USD Million)
Figure 16. World CRISPR Gene Editing Therapy Consumption Value Market Share by Region (2021-2032)
Figure 17. United States CRISPR Gene Editing Therapy Consumption Value (2021-2032) & (USD Million)
Figure 18. China CRISPR Gene Editing Therapy Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe CRISPR Gene Editing Therapy Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan CRISPR Gene Editing Therapy Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea CRISPR Gene Editing Therapy Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN CRISPR Gene Editing Therapy Consumption Value (2021-2032) & (USD Million)
Figure 23. India CRISPR Gene Editing Therapy Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of CRISPR Gene Editing Therapy by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for CRISPR Gene Editing Therapy Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for CRISPR Gene Editing Therapy Markets in 2025
Figure 27. United States VS China: CRISPR Gene Editing Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: CRISPR Gene Editing Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World CRISPR Gene Editing Therapy Market Size by Tool Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World CRISPR Gene Editing Therapy Market Size Market Share by Tool Type in 2025
Figure 31. DNA-Cutting Tools
Figure 32. DNA-Editing Without Double-Strand Breaks
Figure 33. RNA Editing Tools
Figure 34. Others
Figure 35. World CRISPR Gene Editing Therapy Market Size Market Share by Tool Type (2021-2032)
Figure 36. World CRISPR Gene Editing Therapy Market Size by Grade, (USD Million), 2021 & 2025 & 2032
Figure 37. World CRISPR Gene Editing Therapy Market Size Market Share by Grade in 2025
Figure 38. Research Grade
Figure 39. GMP Grade
Figure 40. World CRISPR Gene Editing Therapy Market Size Market Share by Grade (2021-2032)
Figure 41. World CRISPR Gene Editing Therapy Market Size by Product Type, (USD Million), 2021 & 2025 & 2032
Figure 42. World CRISPR Gene Editing Therapy Market Size Market Share by Product Type in 2025
Figure 43. CRISPR-Cas9
Figure 44. CRISPR-Cas12a (Cpf1)
Figure 45. Base Editors (CBE & ABE)
Figure 46. Others
Figure 47. World CRISPR Gene Editing Therapy Market Size Market Share by Product Type (2021-2032)
Figure 48. World CRISPR Gene Editing Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World CRISPR Gene Editing Therapy Market Size Market Share by Application in 2025
Figure 50. Agricultural
Figure 51. Biomedical
Figure 52. Industrial
Figure 53. Others
Figure 54. World CRISPR Gene Editing Therapy Market Size Market Share by Application (2021-2032)
Figure 55. CRISPR Gene Editing Therapy Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. CRISPR Gene Editing Therapy Picture
Figure 2. World CRISPR Gene Editing Therapy Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World CRISPR Gene Editing Therapy Total Revenue (2021-2032) & (USD Million)
Figure 4. World CRISPR Gene Editing Therapy Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World CRISPR Gene Editing Therapy Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company CRISPR Gene Editing Therapy Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company CRISPR Gene Editing Therapy Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company CRISPR Gene Editing Therapy Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company CRISPR Gene Editing Therapy Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company CRISPR Gene Editing Therapy Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company CRISPR Gene Editing Therapy Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company CRISPR Gene Editing Therapy Revenue (2021-2032) & (USD Million)
Figure 13. CRISPR Gene Editing Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World CRISPR Gene Editing Therapy Consumption Value (2021-2032) & (USD Million)
Figure 16. World CRISPR Gene Editing Therapy Consumption Value Market Share by Region (2021-2032)
Figure 17. United States CRISPR Gene Editing Therapy Consumption Value (2021-2032) & (USD Million)
Figure 18. China CRISPR Gene Editing Therapy Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe CRISPR Gene Editing Therapy Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan CRISPR Gene Editing Therapy Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea CRISPR Gene Editing Therapy Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN CRISPR Gene Editing Therapy Consumption Value (2021-2032) & (USD Million)
Figure 23. India CRISPR Gene Editing Therapy Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of CRISPR Gene Editing Therapy by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for CRISPR Gene Editing Therapy Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for CRISPR Gene Editing Therapy Markets in 2025
Figure 27. United States VS China: CRISPR Gene Editing Therapy Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: CRISPR Gene Editing Therapy Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World CRISPR Gene Editing Therapy Market Size by Tool Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World CRISPR Gene Editing Therapy Market Size Market Share by Tool Type in 2025
Figure 31. DNA-Cutting Tools
Figure 32. DNA-Editing Without Double-Strand Breaks
Figure 33. RNA Editing Tools
Figure 34. Others
Figure 35. World CRISPR Gene Editing Therapy Market Size Market Share by Tool Type (2021-2032)
Figure 36. World CRISPR Gene Editing Therapy Market Size by Grade, (USD Million), 2021 & 2025 & 2032
Figure 37. World CRISPR Gene Editing Therapy Market Size Market Share by Grade in 2025
Figure 38. Research Grade
Figure 39. GMP Grade
Figure 40. World CRISPR Gene Editing Therapy Market Size Market Share by Grade (2021-2032)
Figure 41. World CRISPR Gene Editing Therapy Market Size by Product Type, (USD Million), 2021 & 2025 & 2032
Figure 42. World CRISPR Gene Editing Therapy Market Size Market Share by Product Type in 2025
Figure 43. CRISPR-Cas9
Figure 44. CRISPR-Cas12a (Cpf1)
Figure 45. Base Editors (CBE & ABE)
Figure 46. Others
Figure 47. World CRISPR Gene Editing Therapy Market Size Market Share by Product Type (2021-2032)
Figure 48. World CRISPR Gene Editing Therapy Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 49. World CRISPR Gene Editing Therapy Market Size Market Share by Application in 2025
Figure 50. Agricultural
Figure 51. Biomedical
Figure 52. Industrial
Figure 53. Others
Figure 54. World CRISPR Gene Editing Therapy Market Size Market Share by Application (2021-2032)
Figure 55. CRISPR Gene Editing Therapy Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
